WebMay 1, 2005 · Abstract 256 Background The chemokine SDF-1 and its receptor, CXCR4, are involved in the regulation of metastases in many human tumors. Expression of CXCR4 in human osteosarcomas correlates with poor prognosis. SDF-1 is expressed at high levels in lung, bone marrow and liver, all of which are organs to which osteosarcoma can … WebOct 23, 2014 · CXCL10 (IP-10) is a small 10 kDa chemokine with antimicrobial activity. It is induced by IFN-γ, chemoattracts mononuclear cells, and promotes adhesion of T cells. Recently, we detected CXCL10 on the surface of the skin and in the oral cavity. In the current study, we used broth microdilution and radial diffusion assays to show that …
Chemokine Therapeutics Corp. Names Guy Ely, MD As Chief …
WebFeb 6, 2006 · About Chemokine Therapeutics Corp. Chemokine Therapeutics is a product-focused biotechnology company developing drugs that harness the therapeutic potential of stem cells through chemokine pathways. Webche·mo·kine. n. Any of various chemotactic cytokines that are released by several cell types and act to attract monocytes, neutrophils, and other white blood cells to sites of … baja bunga ros
BIOTECH Holdings Ltd., California Oil & Gas Corp., Central Minera Corp …
WebMar 15, 2005 · CHEMOKINE THERAPEUTICS CORP. Dated: March 15, 2005 /s/ Hassan Salari Hassan Salari, President and Chief Executive Officer In accordance with the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates … WebAbout Chemokine Therapeutics Corp. (TSX: CTI, OTCBB: CHKT) Chemokine Therapeutics is a product-focused biotechnology company developing drugs that harness the therapeutic potential of stem cells through chemokine pathways. Chemokines are a class of proteins which signal biological responses from stem cells that play a critical role … WebChemokine Therapeutics Corp. is an early stage biotechnology company developing drugs in the field of chemokines and cytokines. The Company is seeking to discover and … arad doman king